Johnson & Johnson (JNJ) is a leading blue chip company that has typically commanded a premium valuation. It weathered the recession extremely well. In fact better than most. However, its current valuation is significantly below normal.
Today’s video looks at Johnson & Johnson from the perspective of valuation based on earnings.
Best when viewed in full youtube screen.
Disclosure: Author Manages Portfolios Long JNJ
Johnson & Johnson generated a good return for shareholders since 1997 when it was highly valued and through a horrific recession. What do you think it could generate from a low valuation in an improving economy? Judge for yourself.
Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.